Roche Holding AG (ROGN MX) stock market data APIs
6083.8301
0(0%)
as of January 14, 2025
Roche Holding AG Financial Data Overview
Price chart is built with
Anychart
Prev. Close
6083.8301
Open
6083.8301
Volume
0
High
6083.8301
Low
6083.8301
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding AG data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding AG News
New
Roche has no plans for job cuts and business is healthy, CEO says
ZURICH (Reuters) - Swiss pharmaceutical company Roche is not planning job cuts and its business is healthy, CEO Thomas Schinecker was quoted as saying by a Swiss newspaper on Sunday. Roche's share pr...
Roche's Prasinezumab Misses Goal in Parkinson's Disease Study
Roche RHHBY announced data from the phase IIb PADOVA study which evaluated its investigational monoclonal antibody, prasinezumab, for treating people with early-stage Parkinson’s disease. The doubl...
Roche’s Parkinson’s Drug Candidate Misses Key Goal in Mid-Stage Study
An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition. Continue reading View comments
Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease
– PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpoints – – Prasinezumab continues to be well tolerated and no new safety ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
